Ethical approval on Neuren Pharmaceuticals’ Angelman drug study.

- Advertisement -

Neuren Pharmaceuticals (NEU) has received ethics approval to proceed with the phase two clinical study of a treatment for Angelman syndrome in Australia. Angelman syndrome is defined by significant developmental delay and learning difficulties, which manifest as….Read More

Hot this week

Ancient Flying Reptiles Had More Wing Types Than We Knew, Says New Research

Pterosaurs were the first animals with backbones to fly....

Global Study Reveals Teens Are Skipping Healthy Plant-Based Diets—Here’s Why It Matters

Fruits, vegetables, nuts, seeds, beans, and legumes are beneficial...

Canada Introduces Foreign Influence Registry in 2026: What the New Transparency Rules Mean for Foreign Agents

The somewhat-delayed foreign influence registry, initially proposed by former...

UK Tourism Industry 2026: How Policy Changes, Workforce Plans and Connectivity Strategies Will Shape Growth

Supporting the recovery & growth of inbound tourism—Ensuring a...
- Advertisement -

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories